Background: Pulmonary rehabilitation is a program commonly structured for the rehabilitation of chronic lung diseases like COPD, chronic bronchitis, and emphysema. It aims to increase the patients' quality of life by decreasing the symptoms frequently experienced from respiratory diseases. Methods: Forty-two (42) patients aged 40 and above with Chronic Obstructive Pulmonary Disorders will be assessed for eligibility for the study. The study design will be a double-blinded, randomized control trial with three intervention groups and three parallel placebo control groups. ACBT, Autogenic drainage, and Reciprocal pulley exercise will be administered as an intervention in various body positions for 5 minutes, respectively. Ten continuous outcome variables at a different point with a minimum repeated measurement of six per subject will be utilized as an outcome measure. Baseline Pulmonary Function Test (PFT) will be assessed on entry into the study and after every procedure. MRC breathlessness scale, six minutes' walk (6MWT) test, and CAT assessment test will be assessed at every two (2) weeks of the study. Data will be analyzed using descriptive and inferential statistics of repeated ANOVA; P<0.05. Discussion: The study outcome will determine pulmonary rehabilitation's efficacy in various body positions on selected pulmonary parameters of COPD patients and identify the most productive approach among upper limb exercises, autogenic drainage, or ACBT in different fundamental body positionTrial Registration: www.pactr.org: PACTR202005890624077 Keywords: Pulmonary rehabilitation, COPD, 6MWT, PFT, CAT SCORE, MRC Dyspnea scale.
<b>Background</b>: COVID-19 disease is associated with long-term effects in some survivors. There exists dearth of information about the burden of respiratory morbidity among COVID-19 survivors in Nigeria. This study was designed to identify the common respiratory symptoms of long COVID-19 to educate and increase index of suspicion of healthcare practitioners caring for such patient for optimal care.<br /> <b>Material and methods</b>: This is a cross-sectional survey that took place at the adult pulmonology clinic of Lagos State University Teaching Hospital Ikeja. The individuals who were treated for PCR confirmed COVID-19 infection referred for unresolved symptoms 4 weeks following discharge that consented were recruited. A proforma was used to obtain information on socio-demographic characteristics, medical history, and comorbidities. The degree of dyspnea was assessed using MRC(Medical Research Council) dyspnea scale while the functional capacity of patients was assessed using Six-minute walk test (6mwt). The analysis of the data collected was done using descriptive statistics, and chi-square was used to test for association.<br /> <b>Results</b>: Ninety-four subjects participated. The mean age of participants was 49.48±17.8 years, with male: female ratio of 1:1.1. The median duration of admission due to COVID-19 infection was 10.0 (7.0-15.8) days. The common symptoms were fatigue (85.1%), loss of smell (71.3%), dyspnea 53(56.4%), and Cough (62.8%). Dyspnea was present in 62.8% using the MRC dyspnea scale, while the 6-meter walk test showed inadequate functional capacity in 61.7%, and both showed significant association. (X<sup>2</sup>=18.606, P=0.001*)<br /> <b>Conclusion</b>: Respiratory morbidity remains a significant post covid condition. There is a need to raise awareness amongst healthcare workers, particularly within the primary healthcare setting for early identification and referral of COVID-19 survivors with prolonged respiratory symptoms to pulmonology clinics for optimal care. There is also a need for further research on predictors of post COVID syndrome and treatment modalities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.